QY Research, Inc.

Antiviral Drugs Market Is Estimated to Grow CAGR During 2019-2025 : Merck, Novartis, Bristol-Myers Squibb

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

 

Los Angeles, CA -- (SBWIRE) -- 05/29/2019 -- Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.

In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.

This report studies the Antiviral Drugs market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Get PDF of this report template: https://www.qyresearch.com/sample-form/form/1105890/global-antiviral-drugs-market

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Antiviral Drugs in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Roche

Johnson & Johnson

Merck

Novartis

Bristol-Myers Squibb

Gilead Sciences

GlaxoSmithKline

AbbVie

By the product type, the market is primarily split into

Reverse Transcriptase Inhibitors

Protease Inhibitors

Fusion Inhibitors

Immune System Modulators

By the end users/application, this report covers the following segments

Hepatitis Therapeutics

HIV/AIDS Therapeutics

Herpes Therapeutics

Influenza Therapeutics

Get Customized Report in your Inbox within 24 hours @: https://www.qyresearch.com/customize-request/form/1105890/global-antiviral-drugs-market

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

About Us: 
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.